What are the ingredient drugs in Ryzodeg 70/30?
Medically reviewed by Drugs.com. Last updated on Apr 12, 2019.
Ryzodeg 70/30 (insulin degludec/insulin aspart) is formulated with a long-acting insulin analog degludec and a rapid-acting human insulin analog aspart combination, indicated to improve glycemic (blood sugar) control in adults with either type 1 or type 2 diabetes.
Ryzodeg 70/30 can be administered once or twice daily with any main meal.
The most common side effects with Ryzodeg 70/30 include hypoglycemia (low blood sugar), allergic reactions, injection site reactions, pitting at the injection site (lipodystrophy), itching, rash, edema (fluid build-up), and weight gain.
Ryzodeg 70/30 is manufactured by Novo Nordisk in Plainsboro, New Jersey.
Related Medical Questions
- Is Tresiba the same as Lantus?
- Toujeo vs Tresiba - What's the difference between them?
- Does Tresiba cause weight gain?
- How do I use the Tresiba FlexTouch pen?
- How long does Tresiba last?
- What is the difference between Soliqua and Xultophy?